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 Background : In their recent paper Raffaghello,  et al. examined the use 
of short-term starvation (STS) to induce differential stress resistance 
(DSR), that is increased protection of normal over cancer cells against 
chemotherapy-induced oxidative stress, using a range of model organisms. 
 Objective/methods : We examine the results of this study and their significance. 
 Results/conclusions : Raffaghello,  et al. obtained evidence that STS induced 
DSR in yeast, mammalian cell cultures, and mice. It is possible that calorie 
restriction extends lifespan and prevents chronic diseases like tumors, by 
braking proliferation. We think that molecular mechanisms determining 
STS-induced DFS in mammals should be thoroughly studied and clarified 
before starting to test this reasonable strategy in clinical trials. 
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 1.  Introduction 
 Starvation, commonly defined as a prolonged deprivation of food, has been 
recently proposed by Raffaghello,  et al. as a novel strategy to induce differential 
stress resistance (DSR), that is, increased protection of normal over cancer cells 
against chemotherapy-induced oxidative stress  [1] . 
 Tumor cells can proliferate in the absence of stimulatory growth signals, by 
the constitutive activation of one or more cancer-involved pathways, such as 
IGF1-R/Ras/Akt  [2] . Calorie intake reduction as well as dietary restriction have 
been reported previously to downregulate the IGF1 signaling pathway and are 
associated with an increased stress resistance  [3,4] . In yeast, the deletion of 
Saccharomyces protein kinase C homolog 9 (SCH9) and/or ras proto-oncogene 
homolog 2 (RAS2) genes, orthologs of components of the human IGF1-activated 
oncogenic pathway, mimic partially starvation-dependent resistance to oxidative 
stressors and cause proliferation blockage  [5] . 
 Most of chemotherapeutic agents are known to cause DNA damage and/or 
oxidative injury. Although these drugs should be much more toxic to cancerous 
than to normal cells, their selectivity is not complete, so that massive damage 
is delivered not only to tumor cells but also to normal tissues, especially with 
high-dose chemotherapy. 
 To test if a starvation-dependent DSR would be effective in protecting normal 
but not cancer cells against pro-oxidants/chemotherapeutics, the authors 
performed experiments in different models, such as yeast, mammalian cells 
and mice. 
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 2.  Results from the paper 
 To investigate DSR against oxidants and genotoxins in 
yeast, the combination of starvation with the deletion or 
constitutive activation of SCH9 and/or RAS2 genes was 
tested. The authors found that short-term starvation (STS) 
in association with SCH9 and/or RAS2 deletion protected 
cells highly against H 2 O 2 or the superoxide-generating 
agent menadione, compared with RAS2-expressing yeast 
cells. When a mixture of SCH9-lacking (normal-like) and 
RAS2-expressing (tumor-like) yeast cells at a 25:1 ratio was 
exposed to either cyclophosphamide and methylmethane 
sulphonate, a 1,000-fold differential toxicity between 
normal- and tumor-like cells, similar to that observed using 
oxidants, was reported. 
 In order to determine whether the DSR observed in yeast 
would also occur in mammalian cell lines as a result of STS 
obtained by glucose deprivation of the media, primary glial, 
glioma and glioblastoma cells were incubated with increasing 
concentrations of the above mentioned pro-oxidants and 
chemotherapeutic agents. The results confirmed that STS 
could induce different resistance between normal and 
neoplastic cells. 
 Finally, to verify if STS could protect against high-dose 
chemotherapy  in vivo , the survival of prestarved mice 
was compared with that of unstarved controls after an 
unusually high dose of etoposide (80 – 110 mg/kg). Of the 
28 prestarved mice only 1 died after treatment, while more 
than 50% of the 37 non-prestarved mice died of toxicity. 
When neuroblastoma cells were injected into mice to cause 
experimental metastases, which should cause death within 
30 days, the survival of these mice was significantly longer 
with high-dose etoposide given after STS. 
 3.  Signifi cance of the results 
 In the paper by Raffaghello,  et al. , the authors remarked 
that not only new drugs but also different strategies 
ameliorating the risk/benefit ratio of old drugs may offer 
new hopes for cancer patients. 
 In fact, since the era of targeted therapy started, in the 
late 1990s, much time, effort and money have been wasted 
in spasmodic research into biological markers associated 
specifically with carcinogenesis. Unfortunately, even when 
a target is found and blocked no prolonged inhibition 
of cancer cells proliferation can be obtained, due to the 
redundancy of proteins involved in cell-signaling networks. 
 The ‘classic’ cytotoxic agents exert antitumor action 
through killing cells that are actively proliferating 
preferentially, so injuring rapidly dividing cells, such as 
blood cells and the bowel epithelium. 
 Instead of keeping looking for the so-called ‘needle in a 
haystack’, researchers could focus their attention on protecting 
normal tissues from adverse effects of old drugs. A gain in 
drug resistance along with reduced toxicity could be consistent 
with the entry of most of the normally dividing cells, but 
not of the cancer cells, into a cell-cycle-arrested mode. The 
authors suggested that such a ‘high protection’ condition 
could be induced in response to STS and could allow the 
delivery of drug at doses much higher than those commonly 
used in clinical practice. 
 4.  Expert opinion 
 Molecular interactions underlying growth and aging have 
been investigated extensively in yeast and worms and several 
homologous proteins that regulate longevity have been 
identified in IGF1-like pathways  [6] . Common preserved 
growth pathways regulate both cell senescence and tumor 
transformation so that IGF1-receptor signaling is also 
involved highly in cancer development  [7] . It might be 
possible that calorie restriction extends lifespan and prevents 
chronic diseases like tumors, by braking proliferation  [8] . 
The same mechanism has been proposed to protect normal 
cells but not cancer cells whose proliferation is not dependent 
on growth signals, against the toxicity of chemotherapy 
drugs. The 40% decrease in circulating IGF1 levels, 
ascertained in mice after 36 h of starvation, raised the 
possibility that decreasing IGF1 signaling may be involved 
in the protective effect of starvation  [9] . 
 Probably the most relevant finding of the present study is 
that, when high doses of cytotoxic agents are administered 
to prestarved mice, no visible sign of acute toxicity 
is observed, while non-prestarved mice show significant 
toxicity and lose 20 – 30% of their weight following 
chemotherapy. In contrast, prestarved animals gain back the 
weight lost during the starvation period. 
 Experimental data supporting the potential efficacy and 
safety of multiple cycles of STS followed by high-dose 
chemotherapy are still lacking, so that more evidence on 
different types of cancers treated with various chemotherapeutic 
agents are required before clinical evaluation. 
 We think that molecular mechanisms determining 
STS-induced DFS in mammals should be thoroughly 
studied and clarified before starting to test this reasonable 
strategy in clinical trials. 
 Moreover the proposal to reduce dietary intake in cancer 
patients must be carefully evaluated. Tumor growth involves 
profound endocrine and metabolic alterations, which can 
lead to the onset of cancer anorexia–cachexia syndrome 
(CACS), especially when the disease is at an advanced stage. 
CACS is characterized by reduced food intake directly 
related to cancer and its treatment and is associated with 
muscle and fat wasting. Hypercaloric feeding has been 
proposed to reverse the depletion of lean body mass, even if 
metabolic adaptations, in particular the increase in protein 
catabolism, could limit the weight gain. 
 The intuitions by Raffaghello,  et al. should promote new 
studies aimed at finding strategies for protecting normal 
cells against injuries determined by chemotherapy drugs. 
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